Conclusions -Our series suggests that high TSH levels may be involved in the presence of pathological characteristics associated with worse outcome in PTC, but with no statistical significance, unlike to other published series. The only feature actually associated to higher TSH was the presence of autoimmunity. Size of the neoplasm doesn´t relate to preoperative TSH level.
Results -348 patients were included: 92 with incidental microcarcinoma (IMC), 54 with non-incidental microcarcinoma (NIMC) and 202 with PTC larger than 1 cm, 105 of them larger than 2 cm. There were no significant differences in TSH levels among incidental and non-incidental cases. Differences in [TSH] among CPT grouped by size were non-significant. -Neither the presence of multifocality, nor extrathyroidal extension (ETE), nor lymphatic invasion(N1) were associated with TSH levels, although higher [TSH] was found when one of those features was present.
-Aggressive cellular variant or vascular invasion showed lower [TSH].
-Only the presence of antimicrosomal Abs (AcTPO) or diffuse lymphocytic infiltration (LINF) was significantly associated with higher TSH level.
-These results did not change when considering exclusively uninodular non-incidental disease in the analysis. 
